A detailed history of Prairie View Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Prairie View Partners, LLC holds 1,342 shares of JNJ stock, worth $196,482. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,342
Previous 4,742 71.7%
Holding current value
$196,482
Previous $693,000 68.69%
% of portfolio
0.02%
Previous 0.08%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$145.48 - $167.38 $494,631 - $569,092
-3,400 Reduced 71.7%
1,342 $217,000
Q2 2024

Aug 01, 2024

BUY
$144.38 - $157.78 $490,892 - $536,452
3,400 Added 253.35%
4,742 $693,000
Q1 2024

May 03, 2024

SELL
$155.22 - $162.74 $21,730 - $22,783
-140 Reduced 9.45%
1,342 $213,000
Q4 2023

Jan 26, 2024

SELL
$145.6 - $158.88 $10,628 - $11,598
-73 Reduced 4.69%
1,482 $232,000
Q3 2023

Oct 20, 2023

SELL
$155.75 - $174.48 $86,441 - $96,836
-555 Reduced 26.3%
1,555 $242,000
Q2 2023

Aug 04, 2023

SELL
$154.35 - $166.11 $27,474 - $29,567
-178 Reduced 7.78%
2,110 $349,000
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $24,016 - $28,661
-159 Reduced 6.5%
2,288 $354,000
Q4 2022

Jan 30, 2023

BUY
$160.2 - $179.79 $160 - $179
1 Added 0.04%
2,447 $432,000
Q3 2022

Oct 31, 2022

SELL
$161.33 - $179.52 $23,715 - $26,389
-147 Reduced 5.67%
2,446 $400,000
Q2 2022

Jul 22, 2022

BUY
$168.19 - $186.01 $33,638 - $37,202
200 Added 8.36%
2,593 $460,000
Q1 2022

Apr 29, 2022

SELL
$158.14 - $179.59 $113,228 - $128,586
-716 Reduced 23.03%
2,393 $424,000
Q4 2021

Jan 21, 2022

BUY
$155.93 - $173.01 $133,943 - $148,615
859 Added 38.18%
3,109 $532,000
Q3 2021

Oct 12, 2021

BUY
$161.5 - $179.47 $5,975 - $6,640
37 Added 1.67%
2,250 $363,000
Q2 2021

Jul 23, 2021

BUY
$159.48 - $171.07 $318 - $342
2 Added 0.09%
2,213 $365,000
Q1 2021

Apr 21, 2021

SELL
$153.07 - $170.48 $118,476 - $131,951
-774 Reduced 25.93%
2,211 $363,000
Q4 2020

Jan 26, 2021

BUY
$137.11 - $157.38 $7,266 - $8,341
53 Added 1.81%
2,985 $470,000
Q3 2020

Oct 30, 2020

SELL
$140.38 - $153.83 $13,616 - $14,921
-97 Reduced 3.2%
2,932 $436,000
Q2 2020

Jul 28, 2020

BUY
$128.81 - $155.51 $257 - $311
2 Added 0.07%
3,029 $426,000
Q1 2020

Apr 08, 2020

BUY
$111.14 - $153.99 $333 - $461
3 Added 0.1%
3,027 $397,000
Q4 2019

Jan 14, 2020

SELL
$127.5 - $146.44 $30,345 - $34,852
-238 Reduced 7.3%
3,024 $441,000
Q3 2019

Oct 15, 2019

BUY
$126.95 - $142.14 $414,110 - $463,660
3,262 New
3,262 $422,000
Q2 2018

Jul 23, 2018

SELL
$119.4 - $131.76 $245,486 - $270,898
-2,056 Closed
0 $0
Q1 2018

May 01, 2018

BUY
$125.1 - $148.14 $44,160 - $52,293
353 Added 20.73%
2,056 $263,000
Q4 2017

Feb 06, 2018

BUY
$131.22 - $143.62 $223,467 - $244,584
1,703
1,703 $238,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Prairie View Partners, LLC Portfolio

Follow Prairie View Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairie View Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prairie View Partners, LLC with notifications on news.